IDEXX Laboratories Executive Chair Jonathan Jay Mazelsky Reports Sale of $17.68 Million in Common Shares
Bitget2026/11/05 22:25- IDEXX Laboratories Executive Chair of the Board Jonathan Jay Mazelsky sold 25,140 common shares on November 4, 2026.
- Reported sale prices ranged from $698.2625 to $711.9475 per share.
- Mazelsky also exercised non-qualified stock options for 25,140 common shares at $178.26 per share.
- His direct common stock holdings totaled 83,803 shares following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound hits session highs at 1.3420 amid broadbased US Dollar weakness

Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.

Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.